source
- Moderna reports Q1 revenue surge driven by international COVID vaccine sales despite larger net lossModerna posted first‑quarter revenue of $389 million, more than triple the same period a year earlier, primarily from overseas COVID‑19 vaccine sales. The company recorded a net loss of $1.3 billi…
- Axsome receives FDA nod for Alzheimer’s agitation treatmentAxsome announced that the U.S. Food and Drug Administration granted it a nod for a therapy aimed at agitation associated with Alzheimer’s disease, according to the STAT+ report. The decision marks…